ABSTRACT A second allogeneic (allo‐)hematopoietic stem cell transplantation (HSCT2) is a potential curative option for pediatric patients with acute lymphoblastic leukemia (ALL) following relapse after first allogeneic transplantation (HSCT1), but its efficacy is limited by high relapse rates and transplant‐related toxicity in highly pretreated ...
Ava Momm +10 more
wiley +1 more source
A Bibliometric Analysis of Drug Resistance in Pediatric Acute Lymphoblastic Leukemia. [PDF]
Khanahmad A +3 more
europepmc +1 more source
Redefining the role of the transfusion medicine physician in the era of advanced cellular therapies
Transfusion, EarlyView.
Eric A. Gehrie, Kevin J. Land
wiley +1 more source
Extrachromosomal microDNA Signature as a Candidate Biomarker in Pediatric Acute Lymphoblastic Leukemia. [PDF]
Brukner I +8 more
europepmc +1 more source
The Use of Targeted Therapy in Pediatric Acute Lymphoblastic Leukemia: Exploring Novel Approaches and Emerging Therapies. [PDF]
Byrwa DJ +3 more
europepmc +1 more source
A Multicenter Survival Analysis of Adults Type B-Acute Lymphoblastic Leukemia in Ecuador. A Retrospective Study of the Real World. [PDF]
Sabando B +12 more
europepmc +1 more source
EWSR1 Fusion Driven Pediatric B-Acute Lymphoblastic Leukemia: Diagnosis and Review of Literature. [PDF]
Talman M +6 more
europepmc +1 more source
Management of Adult Acute Lymphoblastic Leukemia: A Review. [PDF]
Kantarjian H, Aldoss I, Jabbour E.
europepmc +1 more source
Biallelic Inactivation of NSD1 Associated With Carcinogenesis in Sotos Syndrome
Pediatric Blood &Cancer, Volume 73, Issue 6, June 2026.
Nicholas A. Borja +8 more
wiley +1 more source

